第一单位:
Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK.;School of Cancer Sciences, University of Glasgow, Glasgow, UK.
作者:
Christos,Kiourtis [1]
;
Maria,Terradas-Terradas [1]
;
Lucy M,Gee [2]
;
Stephanie,May [1]
;
Anastasia,Georgakopoulou [3]
;
Amy L,Collins [2]
;
Eoin D,O'Sullivan [4]
;
David P,Baird [5]
;
Mohsin,Hassan [6]
;
Robin,Shaw [3]
;
Ee Hong,Tan [3]
;
Miryam,Müller [3]
;
Cornelius,Engelmann [6]
;
Fausto,Andreola [7]
;
Ya-Ching,Hsieh [8]
;
Lee H,Reed [9]
;
Lee A,Borthwick [9]
;
Colin,Nixon [3]
;
William,Clark [3]
;
Peter S,Hanson [10]
;
David,Sumpton [3]
;
Gillian,Mackay [3]
;
Toshiyasu,Suzuki [3]
;
Arafath K,Najumudeen [3]
;
Gareth J,Inman [1]
;
Andrew,Campbell [3]
;
Simon T,Barry [11]
;
Alberto,Quaglia [12]
;
Christopher M,Morris [13]
;
Fiona E N,LeBeau [13]
;
Owen J,Sansom [1]
;
Kristina,Kirschner [14]
;
Rajiv,Jalan [15]
;
Fiona,Oakley [2]
;
Thomas G,Bird [16]
作者单位:
Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK.;School of Cancer Sciences, University of Glasgow, Glasgow, UK.
[1]
Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
[2]
Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK.
[3]
MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.;Kidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
[4]
MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
[5]
Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
[6]
Liver Failure Group, Institute for Liver and Digestive Health, Division of Medicine, University College London, London, UK.
[7]
School of Cancer Sciences, University of Glasgow, Glasgow, UK.
[8]
Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.;Fibrofind ltd, William Leech Building, Medical School, Newcastle University, Newcastle upon Tyne, UK.
[9]
Medical Toxicology Centre, Edwardson Building, Newcastle University, Health Innovation Neighbourhood, Newcastle upon Tyne, UK.
[10]
Bioscience, Early Oncology, AstraZeneca, Cambridge, UK.
[11]
Department of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.;UCL Cancer Institute, London, UK.
[12]
Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
[13]
Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK.;School of Cancer Sciences, University of Glasgow, Glasgow, UK.;Department of Hematology, Mayo Clinic, Rochester, MN, USA.;Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.;Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
[14]
Liver Failure Group, Institute for Liver and Digestive Health, Division of Medicine, University College London, London, UK.;European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
[15]
Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK. t.bird@crukscotlandinstitute.ac.uk.;School of Cancer Sciences, University of Glasgow, Glasgow, UK. t.bird@crukscotlandinstitute.ac.uk.;MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. t.bird@crukscotlandinstitute.ac.uk.
[16]
DOI
10.1038/s41556-024-01543-3
PMID
39537753
发布时间
2025-01-22